8-K1.01
8-K exhibit
EDGARAmneal Pharmaceuticals, Inc. Class A Common Stock
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) SEC filings
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported AMRX revenue for 2025-09-30 was $784.5M. Net income was $18.1M. Revenue was up 8.3% from 2025-06-30 to 2025-09-30. AMRX currently screens at market cap $5.19B and trailing P/E 44.0. The AMRX filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Amneal Pharmaceuticals, Inc. Class A Common Stock said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
0
10-K
0
10-Q
3
8-K
0
Form 4
Recent filings
EDGAR is the official archive. Browse all AMRX filings.
Frequently asked questions
What did AMRX just say?
AMRX cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.
Where are AMRX SEC filings?
3 cached filings are on this page. EDGAR remains the official archive (CIK 0001723128).
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.